Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04483544
Title Pembrolizumab and Olaparib in Cervical Cancer Patients
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Baptist Health South Florida
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Miami Cancer Institute Miami Florida 33176 United States Details
Miami Cancer Institute at Plantation Plantation Florida 33324 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field